The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of ...

With that, here are two dividend stocks to consider scooping up right now.

Battle Of Galwan teaser has been released on the occasion of Salman Khan's birthday. Here's our detailed trailer review!

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

Bristol Myers Squibb (BMY) is undervalued and poised for growth, with strong dividends and robust financials. Read here for ...

Over the last two years, several IIMs have expanded beyond their flagship MBA programmes by launching undergraduate courses, ...

Bristol Myers (BMY) stock is in focus as the firm to offer its Pfizer (PFE)-partnered Eliquis, free to Medicaid as part of a U.S. pricing deal. Read more here.

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

Even as the Common Entrance Test (CET) for admissions to Bachelor of Management Studies (BMS) and Bachelor of Business Administration (BBA) courses were held twice this year, nearly 65% of seats in ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus erythematosus and plaque psoriasis, and $300 million in funds from Bain Capital.